Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report)’s share price gapped up prior to trading on Tuesday. The stock had previously closed at $10.33, but opened at $10.7550. Santen Pharmaceutical shares last traded at $10.7550, with a volume of 459 shares traded.
Santen Pharmaceutical Stock Down 0.3%
The firm has a 50 day moving average price of $11.40 and a two-hundred day moving average price of $11.74.
About Santen Pharmaceutical
Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and markets prescription ophthalmic medicines and related products used to treat eye diseases and disorders.
Its product portfolio addresses conditions including glaucoma, dry eye disease, retinal diseases, ocular allergies, infections and inflammation. Santen also develops treatments for other serious vision-related conditions and provides products for eye-care professionals and patients.
Founded in 1890 and headquartered in Osaka, Japan, Santen has built a business serving patients and healthcare providers in Japan and international markets, including other parts of Asia, Europe and North America.
Further Reading
- Five stocks we like better than Santen Pharmaceutical
- UnitedHealth Beats on Earnings, But Investors Question Growth Path
- Swarm Economics: Can XTEND AI Robotics Deliver at Scale?
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
